NIH-funded research R01 grant

Assessing the ability of stem cells to develop into retinal cells

Official title: Non-destructive assessment of retinal differentiation capacity and developmental maturity

Funded at University of Iowa · NIH-11040157 · Data updated 2026-11-12

This study is looking to make better stem cell treatments for people with inherited retinal blindness by using a special robot to help create the right kind of cells from each patient, so they can see better in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startMarch 1, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$618,600
NIH project number1R01EY037073-01
Project IDNIH-11040157 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with inherited retinal degenerative conditions who may benefit from stem cell therapies.

Less likely to help

Patients with retinal conditions that are not inherited or those who do not have access to stem cell therapy may not benefit from this research.

What this research studies

This research focuses on improving the production of patient-specific stem cell therapies for treating inherited retinal degenerative blindness. By utilizing a robotic cell culture platform, the study aims to enhance the efficiency of generating induced pluripotent stem cells (iPSCs) that can differentiate into retinal cells. The researchers will investigate the variability in differentiation capacity among different patient-derived iPSC lines to optimize therapeutic outcomes. This approach seeks to address the challenges of traditional manufacturing methods that are not tailored for individual patient needs.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatments for patients suffering from retinal degenerative diseases.

How similar studies have gone: Previous research has shown promise in using stem cell therapies for retinal diseases, indicating that this approach has potential based on earlier successes.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Tucker, Budd a — University of Iowa
  • Study coordinator: Tucker, Budd a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.